e-learning
resources
Monograph
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macrolides as anti-inflammatory agents in CAP
Waleed Salih, Philip M. Short, Stuart Schembri
Source:
Eur Respir Monogr 2014; 63: 243-255
Journal Issue:
Community-Acquired Pneumonia
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Waleed Salih, Philip M. Short, Stuart Schembri. Macrolides as anti-inflammatory agents in CAP. Eur Respir Monogr 2014; 63: 243-255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Novel anti-inflammatory agents
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 876-877
Year: 2015
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 875-876
Year: 2015
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017
Year: 2018
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017
Year: 2018
Mucolytics and anti-inflammatory lung treatments
Source: ERS course 2015
Year: 2015
Non-steroidal anti-inflammatory drug use and clinical outcomes of community-acquired pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Anti-inflammatory therapies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 223-238
Year: 2011
Azithromycin in the anti-inflammatory treatment of children with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004
Long-term macrolide therapy in chronic inflammatory airway diseases
Source: Eur Respir J 2009; 33: 171-181
Year: 2009
Non-antibiotic therapies for CAP
Source: Eur Respir Monogr 2014; 63: 219-233
Year: 2014
Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Update on anti-inflammatory therapy in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Drugs anti-inflammatories
Source: Virtual Congress 2020 – Management
Year: 2020
Switching of antimicrobial agents in the therapy of community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Next generation of anti-inflammatory therapy for COPD?
Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017
Year: 2017
Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving
P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept